IT1263957B - THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY - Google Patents

THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY

Info

Publication number
IT1263957B
IT1263957B ITMI930341A ITMI930341A IT1263957B IT 1263957 B IT1263957 B IT 1263957B IT MI930341 A ITMI930341 A IT MI930341A IT MI930341 A ITMI930341 A IT MI930341A IT 1263957 B IT1263957 B IT 1263957B
Authority
IT
Italy
Prior art keywords
carboxylate
pyrolidon
pyridoxy
therapeutic use
fatty acids
Prior art date
Application number
ITMI930341A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI930341A priority Critical patent/IT1263957B/en
Publication of ITMI930341A0 publication Critical patent/ITMI930341A0/en
Priority to TW082104060A priority patent/TW230749B/zh
Priority to PCT/EP1994/000518 priority patent/WO1994018965A1/en
Publication of ITMI930341A1 publication Critical patent/ITMI930341A1/en
Application granted granted Critical
Publication of IT1263957B publication Critical patent/IT1263957B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Abstract

La somministrazione di pirrolidon carbossilato di piridossina consente di inibire la formazione di esteri etilici degli acidi grassi liberi ed il loro accumulo negli organi animali, nonché di compensare alterazioni delle funzioni enzimatiche connesse con gli acidi grassi liberi ed i loro esteri.The administration of pyridoxine pyrrolidon carboxylate allows to inhibit the formation of ethyl esters of free fatty acids and their accumulation in animal organs, as well as to compensate for alterations in the enzymatic functions associated with free fatty acids and their esters.

ITMI930341A 1993-02-23 1993-02-23 THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY IT1263957B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (en) 1993-02-23 1993-02-23 THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY
TW082104060A TW230749B (en) 1993-02-23 1993-05-22
PCT/EP1994/000518 WO1994018965A1 (en) 1993-02-23 1994-02-19 Therapeutic use of pyridoxine pyrrolidone carboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (en) 1993-02-23 1993-02-23 THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY

Publications (3)

Publication Number Publication Date
ITMI930341A0 ITMI930341A0 (en) 1993-02-23
ITMI930341A1 ITMI930341A1 (en) 1994-08-23
IT1263957B true IT1263957B (en) 1996-09-05

Family

ID=11365120

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930341A IT1263957B (en) 1993-02-23 1993-02-23 THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY

Country Status (3)

Country Link
IT (1) IT1263957B (en)
TW (1) TW230749B (en)
WO (1) WO1994018965A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
JP2002539127A (en) 1999-03-08 2002-11-19 メディキュア インコーポレーテッド Pyridoxal analogs for vitamin B-6 disorders
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
JP2003528146A (en) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド Treatment of cerebrovascular disease
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
AU2007362353A1 (en) * 2007-12-12 2009-06-18 Northern Innovations And Formulations Corp. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
EP2323735A1 (en) 2008-07-29 2011-05-25 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
WO2010150261A1 (en) 2009-06-25 2010-12-29 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485372B1 (en) * 1980-06-30 1985-08-09 Baldacci Lab Spa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE ALCOHOLIC POISONING BASED ON PYRIDOXIN 5-OXO-2-PYRROLIDONE CARBOXYLATE AND PROCESS FOR PREPARING THE SAME

Also Published As

Publication number Publication date
ITMI930341A0 (en) 1993-02-23
TW230749B (en) 1994-09-21
WO1994018965A1 (en) 1994-09-01
ITMI930341A1 (en) 1994-08-23

Similar Documents

Publication Publication Date Title
PT1239849E (en) Pharmaceutical formulations that comprise Resveratrol and its use
DE3850109D1 (en) 13-TRANS RETIC ACID ESTER.
ES2145118T3 (en) DERIVATIVES OF FATTY ACIDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
AR007989A1 (en) A METHOD TO REDUCE THE LEVEL OF LIPIDS IN WHEY, CHOLESTEROL AND / OR TRIGLYCERIDES AND TREAT RELATED DISEASES IN A SPECIES OF MAMMALS BY MEANS OF A MICRO-SUCCOLENT TRANSIGERANT PROTEIN (MICROSOMAL). Y
ATE315388T1 (en) THERAPEUTIC COMBINATIONS OF FATTY ACIDS
SE8702980D0 (en) THERAPEUTIC USE OF SEROTONIN ANTAGONISTS
ES2139132T3 (en) PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY.
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
DE3778699D1 (en) USE OF VITAMIN E FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE NORMALIZATION OF BLOOD COagulation IN THERAPY WITH HIGH-UNSATURATED FATTY ACIDS OF THE OMEGA-3 TYPE.
ES2141925T3 (en) HIGHLY REACTIVE ESTERS OF CARBOXY POLYSACCHARIDES AND NEW CARBOXY POLYSACCHARIDES DERIVED FROM THEM.
DE50010931D1 (en) SUBSTITUTED BENZIMIDAZOLE
WO1995013071A3 (en) Treatment of immunoregulatory disorders
ES2157422T3 (en) TRIGLICERIDS AND ETHYL ESTERS OF PHENYLALCANOIC ACID AND PHENYLALKYEN ACID USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS.
IT1263957B (en) THERAPEUTIC USE OF PYROLIDON CARBOXYLATE OF PYRIDOXY
ES2107707T3 (en) USE OF ESTERS OF L-CARNITINE AND L-CARNITINE ACIL WITH HYDROXIACIDS FOR PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOSIS.
SE9704693D0 (en) Method of the prophylactic treatment of mastitis
MX9400630A (en) 6-CHLORINE-5-FLUORINE-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALGESIC AND ANTI-INFLAMMATORY AGENT.
DE68926115D1 (en) METHOD FOR TREATING ACNE
IT8023656A0 (en) PROCEDURE FOR THE PRODUCTION OF THE ENZYME CHOLESTEROL-ESTERASE AND FOR HYDROLYSIS OF THE ESTERS WITH CHOLESTEROL FATTY ACIDS THROUGH THE USE OF THE ENZYME ITSELF.
AR016382A1 (en) USE OF A BENCIL-INDAZOL METOXIALCANOIC ACID DERIVATIVE.
DE69015910D1 (en) Pharmaceutical use of fatty acids.
ES2072666T3 (en) N-ALKYL 1,4-DIHYDROPYRIDINDICARBOXYL ACID ESTERS.
AR007369A1 (en) THE USE OF CARBOXYLATED DERIVATIVES AND A MEDICINAL PRODUCT CONTAINING ONE OR MORE OF SUCH DERIVATIVES
DE69918152D1 (en) TREATMENT OF DIGESTIVE DISORDERS
ATE97812T1 (en) THERAPEUTIC USE OF THE ISOPROPYLESTER DERIVATIVE OF MONOSIALOGANGLIOSIDS IN DISEASES OF THE NERVOUS SYSTEM ACCOMPANYING INFLAMMATION.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227